Company News

Immodulon appoints new CSO Effective immediately Thomas Kleen will take on the role within the senior management team Dr William F Feehery is new Certara CEO Effective 3 June, Dr William F Feehery will take over the model-informed drug development services company Prudential family leadership goes to third generation John Clark, son of departing CEO, Dan Clark, and third generation family member, will assume the CEO position Asceneuron appoints new Board Member Dr Eric Yuen will join the company and help initiate later stage clinical development in the tau pathology space Mogrify appoints new CBO and COO New executives at the biopharma company will be Dr Karin Schmitt as Chief Business Officer and Joe Foster as Chief Operating Officer Almac Group appoints Dr Sheryl Foster as Vice President of Quality Metrion Biosciences appoints new CEO The promotion of Dr Andrew Southan from COO is effective immediately PCI Pharma Services announces organisation updates Scancell establishes clinical advisory board Board will provide the necessary guidance as cancer immunotherapy company prepares for its lead Moditope candidate to enter the clinic in 2020 Evox hires two experienced new VPs Bo Kara will take over VP of Process Development and Simon Dew will be VP of Business Development ABPI names Novartis MD Haseeb Ahmad as President New Midlands account manager appointed at Burkert Nanoform strengthens GMP capabilities with Head of Manufacturing appointment Dr Mathew Minardi joins Sterling Pharma Solutions Stuart Ashman joins SkinBioTherapeutics Pierre Fabre names new pharma CEO Jean-Luc Lowinski, a former Sanofi executive, spearheads Pierre Fabre Pharmaceuticals

Trending Articles

  1. Chiesi appoints David Khougazian as Group chief executive officer David Khougazian to lead the next phase of innovation-driven growth
  2. Gerresheimer names new Chairman of the Supervisory Board This year's AGM featured the election of four shareholder representatives to the Supervisory Board, including Sieger as Chairman
  3. Scenic Biotech appoints renowned neurology drug development leader Dr. Judith Walker as Chief Medical Officer Dr. Walker joins to lead Scenic's transition into clinical development and shape its clinical strategy
  4. Yusen Logistics appoints Gilbert den Bekker as chief commercial officer for Europe Experienced commercial leader joins Yusen Logistics to support sustainable growth and strengthen commercial collaboration across Europe
  5. Virginie Cavalli appointed Chief Executive Officer of Seppic Seppic announces the appointment of Virginie Cavalli as Chief Executive Officer, effective September 1, 2026

Upcoming event

CPhI Milan

6–8 October 2026 | Exhibition | Fiera Milano, Italy See all